Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial
Jones, J R, Cairns, D A, Gregory, W M, Collett, C, Pawlyn, C, Sigsworth, R, Striha, A, Henderson, R, Kaiser, M F, Jenner, M, Cook, G, Russell, N H, Williams, C, Pratt, G, Kishore, B, Lindsay, J, Drayson, M T, Davies, F E, Boyd, K D, Owen, R G, Jackson, G H, Morgan, G J
Published in Blood cancer journal (New York) (09.12.2016)
Published in Blood cancer journal (New York) (09.12.2016)
Get full text
Journal Article
B455 A Molecular Characterization of 17p Deletion in Myeloma, Related to Maintenance Thalidomide Outcome
Boyd, KD, Walker, BA, Gonzalez, D, Dickens, NJ, Hockley, SL, Ross, FM, Szubert, AJ, Gregory, WM, Davies, FE, Morgan, GJ
Published in Clinical lymphoma & myeloma (01.02.2009)
Published in Clinical lymphoma & myeloma (01.02.2009)
Get full text
Journal Article